title: The Use of Antiangiogenic Agents for Lung Cancer in Elderly Patients: An Expert Panel Discussion Synopsis.
authors.affiliation: University of Pittsburgh, UPMC Cancer Center, Pittsburgh, PA. Electronic address: mark.socinski.md@flhosp.org.
authors.forename: Mark A
authors.initials: MA
authors.lastname: Socinski
authors.affiliation: Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY.
authors.forename: Jamie E
authors.initials: JE
authors.lastname: Chaft
authors.affiliation: Mount Sinai Hospital, Mount Sinai Health System, New York, NY.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Levy
authors.affiliation: Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY.
authors.forename: Gregory J
authors.initials: GJ
authors.lastname: Riely
authors.affiliation: Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
authors.forename: Corey J
authors.initials: CJ
authors.lastname: Langer
authors.affiliation: Montefiore Medical Center, Albert Einstein College of Medicine, Albert Einstein Cancer Center, Bronx, NY.
authors.forename: Roman
authors.initials: R
authors.lastname: Perez-Soler
authors.affiliation: AXIS Medical Education, Fort Lauderdale, FL.
authors.forename: Deborah L
authors.initials: DL
authors.lastname: Middleton
authors.affiliation: AXIS Medical Education, Fort Lauderdale, FL.
authors.forename: Linda
authors.initials: L
authors.lastname: Gracie-King
authors.affiliation: AXIS Medical Education, Fort Lauderdale, FL.
authors.forename: Laura M
authors.initials: LM
authors.lastname: Healy
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000068258:Bevacizumab / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D032921:Consensus; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D020533:Angiogenesis Inhibitors; D000068258:Bevacizumab